new medical entity set appart from MS

A forum to discuss research on the origins of MS and its development.

new medical entity set appart from MS

Postby frodo » Mon Jun 26, 2017 2:28 pm

First it was Neuromyelitis Optica. It was set appart from MS when anti-AQP4 antibodies were found to be specific of this kind of disease.

Then it came "anti-MOG associated encephalomyelitis". It was found that only very atypical MS could present anti-MOG antibodies, and now it is considered a separate disease.

And it has happened again. Around 2% of MS patients have auto-antibodies against a specific protein named flotillin. It seems that anti-flotilin patients will make a new different group.

https://jneuroinflammation.biomedcentra ... 017-0900-z

NOTE: Before publshing the article, it seems that they presented a "poster" in Neurology April 18, 2017 vol. 88 no. 16 Supplement P1.393, available at

http://www.neurology.org/content/88/16_ ... .393.short
User avatar
frodo
Family Elder
 
Posts: 933
Joined: Wed Dec 02, 2009 3:00 pm

Advertisement

Return to MS Etiology and Pathogenesis

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service